Novanta Inc. (NASDAQ:NOVT – Get Free Report) CFO Robert Buckley sold 1,111 shares of the firm’s stock in a transaction on Friday, September 27th. The stock was sold at an average price of $180.45, for a total transaction of $200,479.95. Following the completion of the sale, the chief financial officer now owns 120,419 shares in the company, valued at $21,729,608.55. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
Robert Buckley also recently made the following trade(s):
- On Tuesday, October 1st, Robert Buckley sold 3,660 shares of Novanta stock. The shares were sold at an average price of $174.01, for a total transaction of $636,876.60.
- On Tuesday, September 3rd, Robert Buckley sold 4,379 shares of Novanta stock. The shares were sold at an average price of $176.20, for a total value of $771,579.80.
- On Thursday, August 1st, Robert Buckley sold 4,108 shares of Novanta stock. The stock was sold at an average price of $172.75, for a total value of $709,657.00.
- On Tuesday, July 16th, Robert Buckley sold 1,830 shares of Novanta stock. The shares were sold at an average price of $180.18, for a total value of $329,729.40.
- On Friday, July 12th, Robert Buckley sold 1,830 shares of Novanta stock. The stock was sold at an average price of $170.19, for a total value of $311,447.70.
Novanta Stock Down 2.2 %
Shares of NOVT opened at $171.84 on Friday. The company has a quick ratio of 1.73, a current ratio of 2.77 and a debt-to-equity ratio of 0.68. The company has a 50-day moving average price of $175.12 and a two-hundred day moving average price of $168.57. The stock has a market cap of $6.17 billion, a price-to-earnings ratio of 89.04 and a beta of 1.29. Novanta Inc. has a 12 month low of $111.20 and a 12 month high of $187.12.
Analysts Set New Price Targets
Separately, Robert W. Baird increased their price objective on shares of Novanta from $170.00 to $175.00 and gave the company a “neutral” rating in a research note on Wednesday, August 7th.
Get Our Latest Research Report on Novanta
Institutional Investors Weigh In On Novanta
Several institutional investors and hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. increased its position in shares of Novanta by 1.2% during the 1st quarter. Vanguard Group Inc. now owns 3,861,416 shares of the technology company’s stock worth $674,860,000 after purchasing an additional 45,937 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of Novanta by 4.1% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,007,407 shares of the technology company’s stock worth $350,836,000 after buying an additional 79,718 shares in the last quarter. Conestoga Capital Advisors LLC raised its stake in shares of Novanta by 2.4% in the second quarter. Conestoga Capital Advisors LLC now owns 1,329,826 shares of the technology company’s stock valued at $216,908,000 after acquiring an additional 31,290 shares during the last quarter. William Blair Investment Management LLC boosted its holdings in shares of Novanta by 0.4% in the 2nd quarter. William Blair Investment Management LLC now owns 960,152 shares of the technology company’s stock worth $156,610,000 after acquiring an additional 4,079 shares in the last quarter. Finally, Wasatch Advisors LP boosted its holdings in shares of Novanta by 4.0% in the 1st quarter. Wasatch Advisors LP now owns 958,774 shares of the technology company’s stock worth $167,565,000 after acquiring an additional 37,238 shares in the last quarter. Institutional investors and hedge funds own 98.35% of the company’s stock.
Novanta Company Profile
Novanta Inc, together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation.
Read More
- Five stocks we like better than Novanta
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- When Is the Best Time to Invest in Mutual Funds?
- What is the S&P 500 and How It is Distinct from Other Indexes
- Is NVIDIA Stock in a Correction or Consolidation?
- P/E Ratio Calculation: How to Assess Stocks
- 3 Oversold Stocks with Big RSI Rebound Potential
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.